This inventor holds 3 USPTO granted patents. Top assignee: Sgn Nanopharma Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Innovations by Dinesh Shenoy in Ophthalmic Preparations
Introduction
Dinesh Shenoy, based in Malvern, PA, is a notable inventor with a focus on the development of ophthalmic preparations. With a total of three patents to his name, he has made significant contributions to the field of pharmaceutical formulations, particularly those involving cyclosporine.
Latest Patents
His latest patents include innovative ophthalmic formulations that incorporate cyclosporine. These formulations not only provide new methods for preparing the solution but also offer advanced methods for utilizing the formulations effectively in eye care treatments. The repeat emphasis on these compositions underscores their potential impact on improving patient outcomes in ophthalmic applications.
Career Highlights
Dinesh currently works at Sgn Nanopharma Inc., where his expertise continues to drive research and development in the pharmaceutical industry. His role at the company allows him to collaborate with other professionals, further enhancing his inventions and making strides in ocular health solutions.
Collaborations
Throughout his career, Dinesh has likely engaged with various professionals in the fields of research and pharmaceuticals, contributing to interdisciplinary projects that leverage technology and scientific knowledge. Such collaborations are essential for advancing innovations and speeding up the development process of new treatments.
Conclusion
Dinesh Shenoy's dedication to advancing ophthalmic formulations demonstrates the crucial role of inventors in the medical field. His contributions, particularly in developing cyclosporine-based preparations, not only highlight his inventive spirit but also signify the importance of innovation in improving healthcare solutions. As he continues his work with Sgn Nanopharma Inc., further advancements can be anticipated from this remarkable inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile